Finance

Beta
Lists
KURA:NASDAQ
Kura Oncology Inc
$10.36
-2.45%
(-0.26) 1D
$10.33
-0.34% (-0.035)
After hours
Closed: Jun 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KURA...
Open
$10.63
High
$10.90
Low
$10.32
Mkt. cap
919.70M
Avg. vol.
2.05M
Volume
1.51M
52-wk high
$12.49
52-wk low
$5.45
EPS
-$3.35
Beta
0.36
Shares outstanding
88.77M
No. of employees
260
Open
$10.63
High
$10.90
Low
$10.32
Mkt. cap
919.70M
Avg. vol.
2.05M
Volume
1.51M
52-wk high
$12.49
52-wk low
$5.45
EPS
-$3.35
Beta
0.36
Shares outstanding
88.77M
No. of employees
260
News stories
From sources across the web
About Kura Oncology Inc
CEO-
Employees260
Founded2014
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websitekuraoncology.com
Analyst ratings
Based on 10 analysts giving stock ratings to KURA in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for KURA in the last 3 months.
Highest
Current $10.36
$40.00 (+286.10%)
Average
$28.11 (+171.33%)
Lowest
$15.00 (+44.79%)
Analyst
Recommendation
Action
Price target
Projected
Date
Salim Syed
Mizuho Securities
Buy
Maintained
$25.00
+141.3%
06/23/2026
Unknown Analyst
Jefferies
Buy
Maintained
$28.00
+170.3%
06/15/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$36.00
+247.5%
06/15/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$36.00
+247.5%
06/15/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$28.00
+170.3%
06/15/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$40.00
+286.1%
06/15/2026
Daniel Brims
Lake Street
Buy
Initiated
$23.00
+122%
06/04/2026
Etzer Darout
Barclays
Buy
Maintained
$28.00
+170.3%
06/04/2026
Jason Zemansky
Bank of America Securities
Buy
Reiterated
$30.00
+189.6%
06/03/2026
David Dai
UBS
Buy
Maintained
$15.00
+44.8%
06/03/2026
Unknown Analyst
Lake Street
Buy
Reiterated
$23.00
+122%
05/13/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/12/2026
Unknown Analyst
Guggenheim
Hold
Maintained
-
-
03/06/2026
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.83 / -$0.78
-7.02%miss
Revenue / Est. (USD)
18.26M / 25.92M
-29.53%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.29M
20.75M
17.34M
18.26M
Cost of goods sold
62.78M
67.91M
64.46M
65.52M
Cost of revenue
62.78M
67.91M
64.46M
65.52M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.17M
32.84M
39.14M
31.56M
Operating expense
25.17M
32.84M
39.14M
31.56M
Total operating expenses
87.95M
100.75M
103.60M
97.08M
Operating income
-72.67M
-80.00M
-86.27M
-78.82M
Other non operating income
-
-
-
-
EBT including unusual items
-66.12M
-74.12M
-80.93M
-73.32M
EBT excluding unusual items
-66.12M
-74.12M
-89.42M
-73.32M
Income tax expense
-
-
71.00K
8.00K
Effective tax rate
-
-
-0.09%
-0.01%
Other operating expenses
-
-
-
-
Net income
-66.12M
-74.12M
-81.00M
-73.33M
Net profit margin
-432.51%
-357.19%
-467.23%
-401.49%
Earnings per share
-0.75
-0.85
-0.92
-0.83
Interest and investment income
6.94M
6.27M
-
5.83M
Interest expense
-391.00K
-393.00K
-3.15M
-336.00K
Net interest expenses
6.54M
5.88M
-3.15M
5.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
-72.44M
-79.83M
-85.86M
-78.46M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of KURA
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer